I have a couple of things, I guess.
First, we have a comprehensive risk assessment under way in British Columbia to look at these very issues. It's in its infancy. It is continuing. The new resources that we have through budget 2016 are to augment and expand the disease risk assessment work that's under way now.
The second point is that the level of unanimity in the science community around these issues is, at least in our view, quite low. There is a great deal of debate as to how and when disease arises and how it transmits, and specifically with HSMI, there is quite a bit of controversy and debate in the scientific community about its origin, its passage from farm to wild, or vice versa, and the extent to which it is implicating the industry.
The third point I would make is with respect to the global situation. The strains that we have found in British Columbia of HSMI are genetically different from those in Norway and other European waters. We are very confident that the two disease situations are quite different and we do not have an emphatic conclusion about the future transmission and/or impact of HSMI in British Columbia. We have not detected it anywhere else in Canada.